GET THE APP

..

Metabolomics:Open Access

ISSN: 2153-0769

Open Access

Citations Report

Metabolomics:Open Access : Citations & Metrics Report

Articles published in Metabolomics:Open Access have been cited by esteemed scholars and scientists all around the world.

Metabolomics:Open Access has got h-index 14, which means every article in Metabolomics:Open Access has got 14 average citations.

Following are the list of articles that have cited the articles published in Metabolomics:Open Access.

  2022 2021 2020 2019 2018

Year wise published articles

20 30 24 7 9

Year wise citations received

102 110 105 105 96
Journal total citations count 895
Journal impact factor 1.8
Journal 5 years impact factor 3.73
Journal cite score 2.25
Journal h-index 14
Journal h-index since 2018 9
Important citations

Padhy J, Lakshmi KA (2016) Research and Reviews: Journal of Pharmacognosy and Phytochemistry.Research and Reviews: Journal of Pharmacognosy and Phytochemistry 4: 20-26.

Lu DY, Chen EH, Wu HY, Lu TR, Xu B,et al. (2017) Anticancer drug combinations, how far we can go through?. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 17: 21-28.

Lu DY, Chen EH, Lu TR, Ding J (2015) Anticancer drug combinations, studies from different pathways. Cell Dev Biol 4: 2.

Lu DY, Wu HY, Lu TR, Xu B, Ding J (2016) HIV Vaccination, is Breakthrough Underway?. Reviews on recent clinical trials 11: 145-151.

Lu DY, Lu Y, Che JH, Che JY, Xu B, et al. (2015) HIV vaccination, current drawbacks and future perspective. Int J Pharmaceutical Sci 1: 33-37.

Divya A (2016) Research and Reviews: Journal of Pharmacology and Toxicological Studies. Pp: 182-188.

Thakur C (2016) Research & Reviews: Journal of Medical and Health Sciences.Research & Reviews: Journal of Medical and Health Sciences 5: 1-5.

Lu DY, Lu TR, Xu B, Qi RX, S Yarla N, et al. (2016) Cancer Metastasis, a Clinical Dilemma for Therapeutics. Current Drug Therapy 11: 163-169.

Lu DY, Chen EH, Wu HY, Lu TR, Xu B, et al. (2017) Anticancer drug combinations, how far we can go through?. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 17: 21-28.

Lu DY, Lu TR, Xu B, Ding J (2015) Pharmacogenetics of cancer therapy: breakthroughs from beyond?. Future Science OA 1.

Lu DY, Wu HY, Lu TR, Xu B, Ding J (2016) HIV Vaccination, is Breakthrough Underway?. Reviews on recent clinical trials 11: 145-151.

Lu DY, Lu Y, Che JH, Che JY, Xu B, et al. (2015) HIV vaccination, current drawbacks and future perspective. Int J Pharmaceutical Sci 1: 33-37.

Lu DY, Lu TR, Lu Y, Sastry N, Wu HY (2016) Discover Natural Chemical Drugs in Modern Medicines. Metabolomics (Los Angel) 6: 2153-0769.

Padhy J, Lakshmi KA (2016) Research and Reviews: Journal of Pharmacognosy and Phytochemistry.Research and Reviews: Journal of Pharmacognosy and Phytochemistry 4: 20-26.

Lu DY, Chen EH, Lu TR, Ding J (2015) Anticancer drug combinations, studies from different pathways. Cell Dev Biol 4: 2.

Lu DY, Lu TR, Xu B, Ding J (2016) Pharmacogenetics of cancer therapy: breakthroughs from beyond?. Future Science OA 1.

Liu CJ, Yu SL, Liu YP, Dai XJ, Wu Y, et al. (2016) ynthesis, cytotoxic activity evaluation and HQSAR study of novel isosteviol derivatives as potential anticancer agents. European journal of medicinal chemistry. 115: 26-40.

Kulkarni M (2016) Biofilms: A Policy of Microbes to Strengthen their Viability. Microbiol Int J 1: 104.

Hajizadeh R, Ghaffari S, Rezvanieh Salehi SM, Aghavali S (2016) Association of serum uric acid level with mortality and morbidity of patients with acute ST-elevation myocardial infarction. Journal of Cardiovascular and Thoracic Research 8: 56.

Maharani N, Kuwabara M, Hisatome I (2016) Hyperuricemia and atrial fibrillation. International Heart Journal 57: 395-399.

Relevant Topics

Google Scholar citation report
Citations: 895

Metabolomics:Open Access received 895 citations as per Google Scholar report

Metabolomics:Open Access peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward